Interaction Between Gemcitabine and Topotecan in Human Non-Small-Cell Lung Cancer Cells: Effects on Cell Survival, Cell Cycle and Pharmacogenetic Profile

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6602382
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cancer Stem Cells in Lung Cancer: Distinct Differences Between Small Cell and Non-Small Cell Lung Carcinomas

2011English

ALKBH3, a Human AlkB Homologue, Contributes to Cell Survival in Human Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Comparison of Primary Tumor SUVmax Between Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Current Trends in Clinical & Medical Imaging
2019English

Commentary on “Gemcitabine: Single‐Agent and Combination Therapy in Non‐Small Cell Lung Cancer”

Oncologist
Cancer ResearchMedicineOncology
1999English

FSTL1 Suppresses Tumor Cell Proliferation, Invasion and Survival in Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2017English

Small Cell and Non Small Cell Lung Cancer Form Metastasis on Cellular 4D Lung Model

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Metastatic Non-Small-Cell Lung Cancer and the Use of Gemcitabine During Pregnancy

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2008English

Update on the Role of Topotecan in the Treatment of Non-Small Cell Lung Cancer

Oncologist
Cancer ResearchMedicineOncology
2004English

SHP1-mediated Cell Cycle Redistribution Inhibits Radiosensitivity of Non-Small Cell Lung Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy